Letter: causes of fatigue in inflammatory bowel disease remain uncertain.

@article{Gracie2017LetterCO,
  title={Letter: causes of fatigue in inflammatory bowel disease remain uncertain.},
  author={David J Gracie and Alexander Charles Ford},
  journal={Alimentary pharmacology & therapeutics},
  year={2017},
  volume={45 5},
  pages={
          762-763
        }
}
1. Bendtzen K, Steenholdt C. Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Aliment Pharmacol Ther 2017; 45: 759–60. 2. Ungar B, Kopylov U, Engel T, et al. Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab. Aliment Pharmacol Ther 2017; 45: 276–82. 3. Kopylov U, Mazor Y, Yavzori M, et al. Clinical utility of antihuman lambda chain-based… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-7 OF 7 REFERENCES

Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.

  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2017